International collaboration, funding and association with burden of disease in randomized controlled trials in Africa.

The relevance to Africa of trials conducted in Africa was not adversely affected by collaboration with non-African researchers but funding from private industry was associated with a decreased emphasis on diseases relevant to Africa.